Tuesday July 16, 2019
Home India HC notice to ...

HC notice to govt on Reliance Power plea against coal block cancellation

0
//

Credits: https://www.google.co.in/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0CAYQjB1qFQoTCNvK0pi038YCFQPEjgodQJ8Gkg&url=http%3A%2F%2Fwww.livemint.com%2FCompanies%2FxVzY8KHjnlvpokfvSrVAuM%2FAnil-Ambanis-Reliance-Group-Chinas-Wanda-to-form-JV.html&ei=xIKnVdvYBYOIuwTAvpqQCQ&bvm=bv.97949915,d.c2E&psig=AFQjCNGMFw6B-S3yAE3is9AJqPKKhaUAbg&ust=1437127716377216New Delhi: The Delhi High Court issued notice to the central government on Tuesday, regarding a plea of Reliance Power challenging withdrawal of the Chhatrasal coal block for the company’s Sasan ultra mega power project in Madhya Pradesh.

A division bench of Chief Justice G.Rohini and Justice Jayant Nath sought response from the central government by October 6.

The company in the plea has said the relevant gazette notification of May 7 by which the letter allotting the coal black was cancelled has been challenged. It has contended that prior to bid submission for the projects, three coal blocks – Moher, Moher-Amlohri Extension and Chhatrasal – having a reserve of around 800 million tonnes were set aside for Sasan Power, a wholly-owned subsidiary then of the state-run Power Finance Corp.

Reliance Power has argued that the allocation of the three blocks and the availability of coal in the lifetime of the reserve availability was an integral part of bidding terms and conditions. It was the main reason why a competitive tariff of Rs.1.196 per unit was bid by Reliance Power, it added.

The company has also held that the cancellation of the notification, based on a judgment of the Supreme Court, was not not legally tenable.

It has contended that the Sep 14 order did not make the coal blocks allotted to Sasan project its subject matter.

The company further contended that the court had specifically exempted the blocks in the order.

The Supreme Court had cancelled all but four of the 218 coal blocks that were allocated by the government over the past two decades. But the bench of then Chief Justice R.M. Lodha had exempted four blocks allotted to Reliance Power, NTPC and SAIL.

In April this year, the Anil Ambani-led Reliance Power had said that it has fully attained commercial operations of the Rs.27,000 crore Sasan ultra mega power project, 12 months ahead of schedule, with all the six units generating a total of 3,960 MW of electricity.

The group had also said this was not only the largest integrated coal-mining-cum-power project at a single location in the world, but that the 20-million Moher and Moher-Amlohri mines, which were also fully operational, were the largest in the country.

(IANS)

Next Story

Delhi High Court Directs Private Clinic to Continue with the Stem Cell Treatment

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained

0
Order
Delhi High Court. Source- Wikimedia

In an interim relief, the Delhi High Court has directed a private clinic to continue with the stem cell treatment being provided to the patients till its further orders.

The court’s interim direction came while hearing various petitions challenging the Centre’s decision to put stem cell therapy in the category of new drugs.

The petitioners were being provided stem cell treatment in Nutech Mediworld Clinic in Green Park here.

A Division Bench of justices Anu Malhotra and Talwant Singh said that all details of treatment being provided to the petitioners by the clinic be placed on record with an affidavit.

Representational image.

The court has sought the response of Centre and Indian Council of Medical Research to file reply on the petition and listed the matter for September 4 for further hearing.

The court has directed authorities concerned to examine whether the products being administered to the petitioners, prima facie, fall within the scope of the expression ‘new drugs’ as defined under Rule 2(1) (w) of New Drugs and Clinical Trial Rules, 2019 and communicate the view to the petitioners and the said clinic.

Also Read- LG CNS, Microsoft to Develop Cloud-based Enterprise Solutions

On account of the Centre’s fresh notification on ‘New Drugs and Clinical Rule 2019’, some medications used for the treatment would fall under the definition of ‘new drug’ and require approval from the authority concerned.

The clinic, which is administering the medicine, cannot function under the new rules until the licence is duly obtained. (IANS)